STOCK TITAN

Apnimed (APMD) director reports multi-year stock option awards

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Apnimed, Inc. (APMD) reports that director Gary Sender holds two stock option awards. One option to acquire 51,890 shares of Class A Common Stock has an exercise price of $9.50 and expires on December 12, 2034. Another option to acquire 44,477 shares has an exercise price of $8.15 and expires on July 7, 2036. For each option, 25% of the shares vest after twelve months of continuous service from the specified start date, with the remaining shares vesting in substantially equal quarterly installments over the following 36 months, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Sender Gary
Role Director
Type Security Shares Price Value
holding Stock Option (Right to Buy) F1 -- -- --
holding Stock Option (Right to Buy) F2 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 96,367 shares (Direct)
Footnotes (2)
  1. F1. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 15, 2024, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
  2. F2. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Option exercise price $9.50 Stock Option (Right to Buy) on 51890 underlying Class A Common shares
Underlying shares 51890 shares Class A Common Stock underlying $9.50 stock option
Option expiration 2034-12-12 Expiration date of $9.50 stock option
Option exercise price $8.15 Stock Option (Right to Buy) on 44477 underlying Class A Common shares
Underlying shares 44477 shares Class A Common Stock underlying $8.15 stock option
Option expiration 2036-07-07 Expiration date of $8.15 stock option
Initial vesting portion 25% Portion of each option vesting after twelve months of continuous service
Remaining vesting period 36 months Quarterly vesting period for remaining option shares after initial cliff
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 9.5000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"shares subject to such option vest and become exercisable"
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer"

FAQ

What insider ownership did Gary Sender report on Form 3 for APMD?

Gary Sender reported holding two stock options for Apnimed, Inc., covering 51,890 and 44,477 underlying Class A Common shares, each with specified exercise prices and long-dated expirations, subject to multi-year vesting schedules.

What are the exercise prices of Gary Sender’s stock options in APMD?

Gary Sender’s reported stock options have exercise prices of $9.50 and $8.15 per share. Each option relates to Class A Common Stock and becomes exercisable over time according to its stated vesting schedule, contingent on continuous service.

How many Apnimed (APMD) shares are covered by Gary Sender’s options?

The reported options cover 51,890 and 44,477 underlying shares of Apnimed Class A Common Stock. These options represent potential future share ownership, subject to vesting conditions and exercise at the stated strike prices.

What are the vesting terms of Gary Sender’s $9.50 stock option in APMD?

For the $9.50 option on 51,890 shares, 25% vests after twelve months of continuous service following October 15, 2024. The remaining 75% vests in substantially equal quarterly installments over the next 36 months, contingent on continued service.

What are the vesting terms of Gary Sender’s $8.15 stock option in APMD?

For the $8.15 option on 44,477 shares, 25% vests after twelve months of continuous service following July 7, 2026. The remaining shares vest in substantially equal quarterly installments over 36 months, subject to his continued service.

When do Gary Sender’s Apnimed (APMD) stock options expire?

The $9.50 option on 51,890 shares expires on December 12, 2034, and the $8.15 option on 44,477 shares expires on July 7, 2036. Exercisability depends on satisfaction of each option’s vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Sender Gary

(Last)(First)(Middle)
APNIMED, INC.
39 JOHN F. KENNEDY STREET, 4TH FLOOR

(Street)
CAMBRIDGE MASSACHUSETTS 02138

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/30/2026
3. Issuer Name and Ticker or Trading Symbol
Apnimed, Inc. [ APMD ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (1)12/12/2034Class A Common Stock51,890$9.5D
Stock Option (Right to Buy) (2)07/07/2036Class A Common Stock44,477$8.15D
Explanation of Responses:
1. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 15, 2024, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
2. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Remarks:
Exhibit 24 - Power of Attorney
/s/Kevin R. Lind, Attorney-in-Fact07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)